Status:
UNKNOWN
OA Optimization Program Pilot Trial
Lead Sponsor:
University of Calgary
Collaborating Sponsors:
University of British Columbia
Conditions:
Osteo Arthritis Knee
Osteoarthritis, Knee
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
Total joint replacement is a highly successful treatment option for people affected by severe osteoarthritis (OA), however, the mismatch between resources and demand for this surgery means that many p...
Eligibility Criteria
Inclusion
- body mass index (weight in kilograms divided by height in metres squared) greater than 30
- symptomatic osteoarthritis (referred to the Alberta Hip and Knee Clinic for assessment for total joint replacement surgery)
Exclusion
- Currently following a specialized or therapeutic diet
- pregnant or breastfeeding
- diagnosed with type 1 diabetes
- unable to read or speak English
- unable to use email
- unable to use virtual platforms such as Zoom
Key Trial Info
Start Date :
June 28 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT05389371
Start Date
June 28 2022
End Date
September 30 2025
Last Update
May 22 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University of Calgary
Calgary, Alberta, Canada, T2N 1N4